SkinBioTherapeutics Plc (SBTX.L)

GBp 20.05

(-2.2%)

Operating Expenses Summary of SkinBioTherapeutics Plc

  • SkinBioTherapeutics Plc's latest annual operating expenses in 2022 was 3.08 Million GBP , up 1.47% from previous year.
  • SkinBioTherapeutics Plc's latest quarterly operating expenses in 2023 Q2 was 1.45 Million GBP , down 0.0% from previous quarter.
  • SkinBioTherapeutics Plc reported a annual operating expenses of 2.99 Million GBP in annual operating expenses 2021, up 101.23% from previous year.
  • SkinBioTherapeutics Plc reported a annual operating expenses of 1.48 Million GBP in annual operating expenses 2020, down -7.78% from previous year.
  • SkinBioTherapeutics Plc reported a quarterly operating expenses of 1.65 Million GBP for 2022 Q4, down 0.0% from previous quarter.
  • SkinBioTherapeutics Plc reported a quarterly operating expenses of 1.38 Million GBP for 2022 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of SkinBioTherapeutics Plc (2022 - 2015)

Historical Annual Operating Expenses of SkinBioTherapeutics Plc (2022 - 2015)

Year Operating Expenses Operating Expenses Growth
2022 3.08 Million GBP 1.47%
2021 2.99 Million GBP 101.23%
2020 1.48 Million GBP -7.78%
2019 1.61 Million GBP 19.15%
2018 1.35 Million GBP 44.01%
2017 941.19 Thousand GBP 104.09%
2016 461.15 Thousand GBP 10877.22%
2015 4201.00 GBP 0.0%

Peer Operating Expenses Comparison of SkinBioTherapeutics Plc

Name Operating Expenses Operating Expenses Difference